Compare PRAX & SLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRAX | SLAB |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 7.2B |
| IPO Year | 2020 | 2000 |
| Metric | PRAX | SLAB |
|---|---|---|
| Price | $263.71 | $218.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 11 |
| Target Price | ★ $572.13 | $163.13 |
| AVG Volume (30 Days) | ★ 427.5K | 337.6K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 66.61 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $491,625,000.00 |
| Revenue This Year | N/A | $20.49 |
| Revenue Next Year | $7,758.26 | $16.65 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $37.25 | $115.51 |
| 52 Week High | $366.52 | $219.68 |
| Indicator | PRAX | SLAB |
|---|---|---|
| Relative Strength Index (RSI) | 39.24 | 59.15 |
| Support Level | $157.29 | $215.02 |
| Resistance Level | $342.62 | $219.18 |
| Average True Range (ATR) | 21.68 | 1.42 |
| MACD | -6.71 | -0.16 |
| Stochastic Oscillator | 20.77 | 69.43 |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
Silicon Laboratories Inc Inc is a provider of secure, intelligent wireless technology for a more connected world. The company's integrated hardware and software platform, intuitive development tools, industry ecosystem, and robust support help customers build industrial, commercial, home, and life applications. Company make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with solutions that transform industries, grow economies, and improve lives. Company operates in USA, China, Taiwan and Rest of World, with maximum revenue from rest of the world.